Lyons Gary A
Reporting Owner SEC Filing List

CIK: 0001123343
FormFilerSubject CompanyFiling AgentDateActions
4Statement of changes in beneficial owner...Lyons Gary A12/04/2025
4Statement of changes in beneficial owner...Neurocrine Biosciences Inc12/04/2025
144Filing for proposed sale of securities u...Lyons Gary AMorgan Stanley Smith Barney Llc Executive Services /fa12/03/2025
144Filing for proposed sale of securities u...Neurocrine Biosciences IncMorgan Stanley Smith Barney Llc Executive Services /fa12/03/2025
4Statement of changes in beneficial owner...Lyons Gary ANeurocrine Biosciences Inc /fa05/22/2025
4Statement of changes in beneficial owner...Neurocrine Biosciences IncNeurocrine Biosciences Inc /fa05/22/2025
4Statement of changes in beneficial owner...Travere Therapeutics, Inc.Sec Connect /fa05/16/2025
144Filing for proposed sale of securities u...Travere Therapeutics, Inc.Morgan Stanley Smith Barney Llc Executive Services /fa10/04/2024
144Filing for proposed sale of securities u...Lyons Gary AMorgan Stanley Smith Barney Llc Executive Services /fa10/04/2024
4Statement of changes in beneficial owner...Travere Therapeutics, Inc.Sec Connect /fa10/04/2024
Load More

Lyons Gary A 's Ownership Transactions

IssuerFiling
Date
Transaction
Date
Transaction
Type
SharesPriceTotal AmtShares Owned